Maternal prepregnancy obesity is an independent risk factor for frequent wheezing in infants by age 14 months

Stefano Guerra1, Claudio Sartini, Michelle Mendez

  • 1Centre for Research in Environmental Epidemiology, Barcelona, Spain. sguerra@creal.cat

Insights

Maternal obesity during pregnancy increases the risk of frequent infant wheezing by 14 months. This highlights the impact of in utero exposures on early asthma development.

Area of Science:

  • Pediatric Health
  • Obstetrics
  • Epidemiology

Background:

  • Maternal prepregnancy obesity is a known risk factor for childhood asthma.
  • Early life wheezing phenotypes are critical indicators for potential respiratory issues.

Purpose of the Study:

  • To investigate the association between maternal prepregnancy obesity and the risk of wheezing phenotypes in early childhood.
  • To determine if maternal obesity influences the incidence of frequent or infrequent wheezing in infants.

Main Methods:

  • Utilized data from 1107 mother-child pairs in the INMA birth cohort study.
  • Maternal prepregnancy body mass index (BMI) was categorized; child wheezing was assessed via questionnaires up to 14 months.
  • Infant weight-for-length z-scores were computed and included as covariates in adjusted models.

Main Results:

  • Maternal obesity was significantly associated with an increased risk of frequent wheezing (adjusted RR 4.18, 95% CI 1.55-11.3).
  • No significant association was found between maternal obesity and infrequent wheezing (adjusted RR 1.05, 95% CI 0.55-2.01).
  • Children of obese mothers had a higher prevalence of frequent wheezing (11.8%) compared to children of normal-weight mothers (3.8%).

Conclusions:

  • Maternal prepregnancy obesity is an independent risk factor for frequent infant wheezing by 14 months of age.
  • These findings underscore the importance of the in utero environment in shaping offspring's respiratory health and asthma risk.
  • Early identification and management of maternal obesity may be crucial for preventing infant respiratory problems.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...